Hmmm, fenfluramine has been approved for the past 20 years or so.  Are you
sure isn’t not dexfenfluramine you’re talking about?  An application for
FDA approval of dexfenfluramine was pending.

  >Anyone have info on this drug for weight loss?
  >I understand that the University of Rochester did a test on this drug.
  >Actually, two drugs were used:  Ionamin and Pondamin.

Ionamin is a tradename for phentermine, an amphetamine-like drug
used as an appetite suppressant.  Pondimin is the tradename for
racemic (50/50 dextro and levo isomer) fenfluramine, a serotonergic
drug also used as an appetite suppressant.  Dexfenfluramine
is just the dextro isomer, which is preferable, since the levo isomer
has no effect on appetite or satiety.  The Weintraub study used a
regimen in which phentermine was given in the morning, and fenfluramine
given in the evening, the rationale being that some of the side effects
of each drug would complement each other (phentermine can cause insomnia
if taken too late in the day, whereas fenfluramine usually causes sedation.)

Here’s the reference to the Weintraub U. Rochester study:

Weintraub, et. al., Long-term weight control study.
Clin Pharmacol Ther (1992 May) 51(5):586-641
      I (weeks 0 to 34). The enhancement of behavior modification, caloric
        restriction, and exercise by fenfluramine plus phentermine versus
        placebo.
     II (weeks 34 to 104). An open-label study of continuous fenfluramine plus
        phentermine versus targeted intermittent medication as adjuncts to
        behavior modification, caloric restriction, and exercise.
    III (weeks 104 to 156). An open-label study of dose adjustment of
        fenfluramine and phentermine.
     IV (weeks 156 to 190). The second double-blind phase.
      V (weeks 190 to 210). Follow-up of participants after cessation
        of medication.
     VI Individual participant response patterns.
    VII (weeks 0 to 210). Serum lipid changes.

–
Steve Dyer
d…@ursa-major.spdcc.com

Note that mail order is not necessarily the least expensive way to secure
drugs. It depends on the drug and where the patients reside.

>1)M1: YOU ASKED THE DIFFERENCE BETWEEN ‘ALTERED STATES’ AND

1) Learn how to turn off your caps lock.

>5)M1:OK…. SINCE THERE ARE 50+: 5-HT RECEPTOR TYPES FOUND IN THE
>BRAIN, AND WE USE, what percent of our brain???,

2) all of it.  the 10% is a silly myth based on considering glial cells
to be "unused" parts of the brain.

>6)M1:PERHAPS YOU SHOULD EXPERIENCE THIS PROFOUND, HUMAN
>EXPERIENCE?

3) been there, done that.  perhaps you should get in touch with the
consensus reality?

>NIGHT. (NO FLAME) FUNCTIONAL AT A HIGHER LEVEL, REFERS TO THE
>MIND HAVING ACCESS TO VARIOUS PSYCHIC CAPACITIES ie. ABILITY TO
>TRANSMIT THOUGHTS, TO A CERTAIN DEGREE, OR SUPERSENSITIVE
>HEARING… ETC.

4) …or magical thinking secondary to a psychotic episode.

>HOW
>MANY PSYCHIATRIST’S TRIED SOME OF THE ANTIPSYCHOTIC MEDICINES? DO
>THEY REALISE THE ‘HELLISH ANGUISH’ SOME OF THESE MEDS HAVE ON THE
>MIND? DO THEY DARE TRY THEM JUST TO UNDERSTAND THE POINT?

5) as has been posted the psychiatrists see the people who are
smearing excrement on their bedroom walls and thinking that
Bill Clinton is sending them personal secret messages over CNN.

>HAVE GREAT RESPECT…. FOR ADVANCING OUR STUDIES IN NEUROSCIENCE
>SINCE THE DAY’S OF "TABOO" OVER THIRTY YEARS AGO. MAY THEY LIVE
>IN FREEDOM FOREVER FOR BEING BORN WITH ADMIRABLE GENIUS. PEACE
>WORLD.       M1

6) persecution complexes are wonderful psychological defense mechanisms.

7) thank you for reminding me why LSD needs to be used very cautiously.

–
Lamont Granquist (lamo…@u.washington.edu)

Nigel.

Kenneth Henson (PSQS…@prodigy.com) wrote:

: My name is Officer Candidate Ken Henson.  I represent 9 Army Physician
: Assistant students finishing their last year of school @ the Blanchfield
: Army Community Hospital, Ft. Campbell, KY.  We are currently seeking
: Pharmaceutical representatives to act as guest speekers during our self
: structured training every wednesday @ noon. We are currently scheduling
: through the month of August, and have many openings.   If interested,
: please contact me at:  PSQS…@prodigy.com .    Thank you for your
: response.
:                                                                            
:        O.C. Ken Henson
: –
:   KENNETH HENSON  PSQS…@prodigy.com

m…@pharmacy.wisc.edu (Micheal Pitterle) wrote:

> In article <3i5bhj$…@newsbf02.news.aol.com> jmarkgr…@aol.com (Jmarkgrice) writes:

> >Has anyone successfully implemented an Indigent Drug Program where free
> >drugs are provided to an indigent patient from the drug manufacturer?

> You can call the PMA at 1-800-762-4636 (PMA Info) for information on obtaining
> the 1994 Directory of Drug Indigent Program.  This book explains the programs
> of the different drug companies.  It covers the drugs eligible for the program
> and process to receive the drug from that company.

> Some clinics have one person in charge of organizing and completing all the
> necessary paper work for the program.

> Michael Pitterle                      m…@pharmacy.wisc.edu
> School of Pharmacy                    (608) 262-9477
> University of Wisconsin – Madison     FAX (608) 265-5421
> 425 N Charter St
> Madison, WI 53706-1515

==================================================================================
  Two other sources of information and help that you can use are the following:

The University Hospital Consortium’s Technology Advancement Center has published a nice
monograph entitled  "Technology Reimbursement Strategy:  Pharmaceutical Industry-
Sponsered Reimbursement Assistance Programs"  Call, write or fax to the

Director of Technology Reimbursement Service
Technology Advancement Center
2001 Spring Road, Suite 700              **Must purchase monograph**
Oak Brook, IL  60521-1890

TEL:  (708)954-1700
FAX:  (708)954-5879

  Alternatively, there is a company, that for a modest fee will assists Phamacists
and clinics, work with patients directly to expedite reimbursement from the various
manufacturers.  They are:

Indegent Patient Services
3820 Gunn Highway, Suite 201
Tampa, Florida  33624

TEL:  (813)962-3576
FAX:  (813)948-1439

I’ve not tried them yet but we’re getting ready to implement an entire program
for our outpatient clinics.

Burt Finkelstein, Pharm.D., Director
Pharmacy and Management Services
Johns Hopkins Bayview Medical Center
4940 Eastern Avenue
Baltimore,  MD   21224

TEL:  (410)550-0962
FAX:  (410)550-0965

eMail:  bfin…@welchlink.welch.jhu.edu

You can call the PMA at 1-800-762-4636 (PMA Info) for information on obtaining
the 1994 Directory of Drug Indigent Program.  This book explains the programs
of the different drug companies.  It covers the drugs eligible for the program
and process to receive the drug from that company.

Some clinics have one person in charge of organizing and completing all the
necessary paper work for the program.

Michael Pitterle                      m…@pharmacy.wisc.edu
School of Pharmacy                    (608) 262-9477
University of Wisconsin – Madison     FAX (608) 265-5421
425 N Charter St
Madison, WI 53706-1515

The answer is yes and the physician can contact the drug manufacturer
directly for the individual company procedures on their version of the
program.

Joe